213 related articles for article (PubMed ID: 28390968)
1. Inhibition of substance P-induced defensive behavior via neurokinin-1 receptor antagonism in the central and medial but not basolateral nuclei of the amygdala in male Wistar rats.
Bassi GS; Carvalho MC; Almada RC; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():146-154. PubMed ID: 28390968
[TBL] [Abstract][Full Text] [Related]
2. Dorsal periaqueductal gray post-stimulation freezing is counteracted by neurokinin-1 receptor antagonism in the central nucleus of the amygdala in rats.
Carvalho MC; Santos JM; Brandão ML
Neurobiol Learn Mem; 2015 May; 121():52-8. PubMed ID: 25883049
[TBL] [Abstract][Full Text] [Related]
3. Effects of substance P and Sar-Met-SP, a NK1 agonist, in distinct amygdaloid nuclei on anxiety-like behavior in rats.
Bassi GS; de Carvalho MC; Brandão ML
Neurosci Lett; 2014 May; 569():121-5. PubMed ID: 24708929
[TBL] [Abstract][Full Text] [Related]
4. Participation of NK1 receptors of the amygdala on the processing of different types of fear.
Carvalho MC; Santos JM; Bassi GS; Brandão ML
Neurobiol Learn Mem; 2013 May; 102():20-7. PubMed ID: 23567110
[TBL] [Abstract][Full Text] [Related]
5. Behavioral sensitization induced by dorsal periaqueductal gray electrical stimulation is counteracted by NK1 receptor antagonism in the ventral hippocampus and central nucleus of the amygdala.
Carvalho MC; Veloni AC; Genaro K; Brandão ML
Neurobiol Learn Mem; 2018 Feb; 148():60-68. PubMed ID: 29519453
[TBL] [Abstract][Full Text] [Related]
6. Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.
Bassi GS; Broiz AC; Gomes MZ; Brandão ML
Psychopharmacology (Berl); 2009 May; 204(1):13-24. PubMed ID: 19093101
[TBL] [Abstract][Full Text] [Related]
7. Anxiogenic effects of activation of NK-1 receptors of the dorsal periaqueductal gray as assessed by the elevated plus-maze, ultrasound vocalizations and tail-flick tests.
Bassi GS; Nobre MJ; de Araújo JE; Brandão ML
Neuropeptides; 2007 Dec; 41(6):365-74. PubMed ID: 17981325
[TBL] [Abstract][Full Text] [Related]
8. Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats.
Ebner K; Rupniak NM; Saria A; Singewald N
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4280-5. PubMed ID: 15024126
[TBL] [Abstract][Full Text] [Related]
9. Substance P injected into the dorsal periaqueductal gray causes anxiogenic effects similar to the long-term isolation as assessed by ultrasound vocalizations measurements.
Bassi GS; Nobre MJ; Carvalho MC; Brandão ML
Behav Brain Res; 2007 Sep; 182(2):301-7. PubMed ID: 17208313
[TBL] [Abstract][Full Text] [Related]
10. Involvement of midbrain tectum neurokinin-mediated mechanisms in fear and anxiety.
Brenes JC; Broiz AC; Bassi GS; Schwarting RK; Brandão ML
Braz J Med Biol Res; 2012 Apr; 45(4):349-56. PubMed ID: 22392188
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.
Salomé N; Stemmelin J; Cohen C; Griebel G
Psychopharmacology (Berl); 2006 Aug; 187(2):237-44. PubMed ID: 16779555
[TBL] [Abstract][Full Text] [Related]
12. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei.
Moreira CM; Masson S; Carvalho MC; Brandão ML
Brain Res Bull; 2007 Mar; 71(5):466-74. PubMed ID: 17259015
[TBL] [Abstract][Full Text] [Related]
13. Effects of neurokinin-1 and 3-receptor antagonists on the defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray.
Broiz AC; Bassi GS; De Souza Silva MA; Brandão ML
Neuroscience; 2012 Jan; 201():134-45. PubMed ID: 22123168
[TBL] [Abstract][Full Text] [Related]
14. Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats.
Duarte FS; Testolin R; De Lima TC
Behav Brain Res; 2004 Oct; 154(2):501-10. PubMed ID: 15313039
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
De Araújo JE; Huston JP; Brandão ML
Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
[TBL] [Abstract][Full Text] [Related]
16. Effects of substance P microinjections into the globus pallidus and central nucleus of amygdala on passive avoidance learning in rats.
Kertes E; László K; Berta B; Lénárd L
Behav Brain Res; 2009 Mar; 198(2):397-403. PubMed ID: 19071162
[TBL] [Abstract][Full Text] [Related]
17. Medial amygdaloid suppression of predatory attack behavior in the cat: I Role of a substance P pathway from the medial amygdala to the medial hypothalamus.
Han Y; Shaikh MB; Siegel A
Brain Res; 1996 Apr; 716(1-2):59-71. PubMed ID: 8738221
[TBL] [Abstract][Full Text] [Related]
18. Microinjection of naltrexone into the central, but not the basolateral, amygdala blocks the anxiolytic effects of diazepam in the plus maze.
Burghardt PR; Wilson MA
Neuropsychopharmacology; 2006 Jun; 31(6):1227-40. PubMed ID: 16123750
[TBL] [Abstract][Full Text] [Related]
19. Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle.
Zhao Z; Yang Y; Walker DL; Davis M
Neuropsychopharmacology; 2009 Jan; 34(2):331-40. PubMed ID: 18418359
[TBL] [Abstract][Full Text] [Related]
20. Amygdaloid involvement in the defensive behavior of mice exposed to the open elevated plus-maze.
Sorregotti T; Cipriano AC; Cruz FC; Mascarenhas DC; Rodgers RJ; Nunes-de-Souza RL
Behav Brain Res; 2018 Feb; 338():159-165. PubMed ID: 29080676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
